SpectraWAVE, Inc is a medical technology company based in Bedford, MA, dedicated to improving outcomes in percutaneous coronary intervention (PCI). With a focus on providing physicians with comprehensive and actionable information, SpectraWAVE has developed the HyperVue Imaging System, a simple yet powerful package that offers a more complete picture of coronary arteries for patients undergoing interventional procedures.
Founded by renowned clinical advisors and driven by a team of experienced professionals, SpectraWAVE aims to enhance patient care by detecting lipid-core containing plaques, assessing coronary artery lipid core burden, and identifying patients and plaques at increased risk of major adverse cardiac events. With their innovative technology and commitment to advancing cardiovascular medicine, SpectraWAVE is poised to make a significant impact in the field of interventional cardiology.
Generated from the website